1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ah 21-132 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ah 21-132) | Trials (ah 21-132) | Recent Studies (post-2010) (ah 21-132) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 19 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitagaki, K; Koda, A; Nagai, H; Tsuruoka, N; Yamaguchi, S | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ah 21-132
| Article | Year |
|---|---|
Priming with murine recombinant interleukin-5 resulted in the augmentation of PAF-induced airway hyperresponsiveness to histamine in guinea pigs.
Topics: Aminophylline; Animals; Bronchoconstriction; Guinea Pigs; Histamine; Interleukin-5; Leukocyte Count; Male; Naphthyridines; Phosphodiesterase Inhibitors; Platelet Activating Factor; Purinones; Recombinant Proteins | 1993 |